Healx is a Cambridge, UK-based company passionate about finding new therapeutic solutions for rare diseases. The company uses advanced data analytics, including machine learning and modern computational biology techniques to identify novel drug applications in the area of rare disorders.
Their unique model places patient advocacy groups at the heart of the drug discovery process, leading the way to personalized medicine for rare diseases.
Listed in 2017 as a ‘Leading Global Innovator’ in Disrupt 100 and awarded ‘Cambridge Graduate Startup of the Year’ in 2016, Healx is considered as one of the leading startups of the Cambridge cluster.
In the media
26th July 2018
Healx raises $10m as investors back AI to find rare disease treatments faster
Cambridge, UK – 26th July, 2018 – Healx (https://healx.io), the Cambridge (UK) technology company developing breakthrough treatments for rare diseases, today announced a $10 million Series A funding round, led by Balderton Capital, Europe's leading early-stage venture investor. Existing investors, Jonathan Milner and Amadeus Capital Partners also participated in the round.
19th February 2019
How Artificial Intelligence Is Revolutionizing Healthcare Sector in 2019
An even cooler example of unsupervised learning is a company called HealX which uses AI to discover new drugs for rare diseases. And it does so by trying to create new
17th February 2019
Why Your Next Startup Should Focus on Healthcare
Companies such as Healx are beginning to harness the power of AI for just this purpose. Healx uses machine learning to improve drug discovery and help find cures for rare diseases,